FIM
INO icon

Freedom Investment Management’s Inovio Pharmaceuticals INO Stock Holding History

Freedom Investment Management’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,387
Closed -$33.3K – 407
2025
Q2 		$33.3K Sell
16,387
-2,783
-15% -$5.33K ﹤0.01% 727
2025
Q1 		$31.2K Buy
+19,170
New +$38.5K ﹤0.01% 731
2023
Q4 		– Sell
-5,192
Closed -$24.2K – 770
2023
Q3 		$24.2K Buy
5,192
+3,105
+149% +$17.2K ﹤0.01% 664
2023
Q2 		$11.2K Sell
2,087
-122
-6% -$983 ﹤0.01% 697
2023
Q1 		$21.7K Sell
2,209
-73
-3% -$1.24K ﹤0.01% 695
2022
Q4 		$42.7K Sell
2,282
-66
-3% -$1.5K ﹤0.01% 695
2022
Q3 		$48.6K Sell
2,348
-151
-6% -$3.87K 0.01% 707
2022
Q2 		$51.9K Buy
2,499
+551
+28% +$15.5K 0.01% 711
2022
Q1 		$84K Sell
1,948
-138
-7% -$6.22K 0.01% 751
2021
Q4 		$125K Sell
2,086
-55
-3% -$4.41K 0.01% 831
2021
Q3 		$184K Sell
2,141
-91
-4% -$9.13K 0.01% 775
2021
Q2 		$248K Buy
2,232
+420
+23% +$40.3K 0.02% 760
2021
Q1 		$202K Buy
+1,812
New +$238K 0.02% 788

Other funds holding INO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Freedom Investment Management's INO Position: Q3 2025 in Review

Freedom Investment Management sold out of Inovio Pharmaceuticals (INO) in Q3 2025, closing a stake of 16,387 shares — an estimated $33.3K sold.

Freedom Investment Management first reported a position in INO in Q1 2021 and held it in 13 quarters. The position peaked at $248K in Q2 2021. 99 funds tracked by Wall St. Rank hold INO as of Q3 2025.

  • Freedom Investment Management reported no remaining Inovio Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Freedom Investment Management sold 16,387 Inovio Pharmaceuticals shares in Q3 2025, an estimated $33.3K.
  • Freedom Investment Management first reported a position in Inovio Pharmaceuticals in Q1 2021 and held it in 13 quarters.
  • Freedom Investment Management's Inovio Pharmaceuticals position peaked at $248K in Q2 2021.
  • 99 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2025.

Based on Freedom Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.